rs1043996

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000435.3(NOTCH3):​c.2538C>T​(p.Cys846Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.682 in 1,613,270 control chromosomes in the GnomAD database, including 385,251 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 27881 hom., cov: 31)
Exomes 𝑓: 0.69 ( 357370 hom. )

Consequence

NOTCH3
NM_000435.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12O:1

Conservation

PhyloP100: 0.347

Publications

35 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 19-15184323-G-A is Benign according to our data. Variant chr19-15184323-G-A is described in ClinVar as Benign. ClinVar VariationId is 256129.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.347 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.713 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOTCH3NM_000435.3 linkc.2538C>T p.Cys846Cys synonymous_variant Exon 16 of 33 ENST00000263388.7 NP_000426.2 Q9UM47
NOTCH3XM_005259924.5 linkc.2410+583C>T intron_variant Intron 15 of 31 XP_005259981.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOTCH3ENST00000263388.7 linkc.2538C>T p.Cys846Cys synonymous_variant Exon 16 of 33 1 NM_000435.3 ENSP00000263388.1 Q9UM47
NOTCH3ENST00000601011.1 linkc.2407+583C>T intron_variant Intron 15 of 22 5 ENSP00000473138.1 M0R3C9

Frequencies

GnomAD3 genomes
AF:
0.572
AC:
86879
AN:
151898
Hom.:
27883
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.627
Gnomad AMR
AF:
0.556
Gnomad ASJ
AF:
0.669
Gnomad EAS
AF:
0.598
Gnomad SAS
AF:
0.662
Gnomad FIN
AF:
0.761
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.718
Gnomad OTH
AF:
0.595
GnomAD2 exomes
AF:
0.641
AC:
160953
AN:
251120
AF XY:
0.653
show subpopulations
Gnomad AFR exome
AF:
0.256
Gnomad AMR exome
AF:
0.504
Gnomad ASJ exome
AF:
0.675
Gnomad EAS exome
AF:
0.606
Gnomad FIN exome
AF:
0.756
Gnomad NFE exome
AF:
0.716
Gnomad OTH exome
AF:
0.653
GnomAD4 exome
AF:
0.694
AC:
1013564
AN:
1461254
Hom.:
357370
Cov.:
50
AF XY:
0.694
AC XY:
504333
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.244
AC:
8161
AN:
33470
American (AMR)
AF:
0.510
AC:
22799
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.676
AC:
17654
AN:
26134
East Asian (EAS)
AF:
0.613
AC:
24332
AN:
39690
South Asian (SAS)
AF:
0.646
AC:
55747
AN:
86244
European-Finnish (FIN)
AF:
0.758
AC:
40380
AN:
53292
Middle Eastern (MID)
AF:
0.612
AC:
3525
AN:
5764
European-Non Finnish (NFE)
AF:
0.721
AC:
801274
AN:
1111584
Other (OTH)
AF:
0.657
AC:
39692
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
16323
32646
48969
65292
81615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19744
39488
59232
78976
98720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.572
AC:
86891
AN:
152016
Hom.:
27881
Cov.:
31
AF XY:
0.574
AC XY:
42671
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.263
AC:
10916
AN:
41460
American (AMR)
AF:
0.556
AC:
8494
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.669
AC:
2322
AN:
3472
East Asian (EAS)
AF:
0.599
AC:
3083
AN:
5150
South Asian (SAS)
AF:
0.663
AC:
3188
AN:
4810
European-Finnish (FIN)
AF:
0.761
AC:
8039
AN:
10558
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.718
AC:
48844
AN:
67986
Other (OTH)
AF:
0.595
AC:
1253
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1641
3282
4924
6565
8206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.671
Hom.:
115940
Bravo
AF:
0.541
Asia WGS
AF:
0.602
AC:
2091
AN:
3478
EpiCase
AF:
0.705
EpiControl
AF:
0.698

ClinVar

Significance: Benign
Submissions summary: Benign:12Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 14, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:3Other:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 17, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect - CureCADASIL
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 06-21-2005 by Lab or GTR ID 1012. GenomeConnect-CureCADASIL assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. -

Lateral meningocele syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
6.1
DANN
Benign
0.38
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1043996; hg19: chr19-15295134; COSMIC: COSV54643242; COSMIC: COSV54643242; API